Page 18 - Ahmad Doroudian News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NA Proactive news snapshot: BioHarvest Sciences Inc, Kainantu Resources Ltd, KushCo Holdings Inc, Nextleaf Solutions Ltd UPDATE …

NA Proactive news snapshot: BioHarvest Sciences Inc, Kainantu Resources Ltd, KushCo Holdings Inc, Nextleaf Solutions Ltd UPDATE …
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesEsmeralda countyEastern highlandsPapua new guineaBritish columbiaSan diegoFrieda riverEast sepikMay riverMark jensenDerrick welshAhmad doroudianHugh rogersMarco romeroDaniel cruzNick kovacevich

BetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of Directors

BetterLife Pharma Inc., an emerging biotech company, is pleased to announce that it has appointed Mr. Henri Sant-Cassia, co-founder of The Conscious Fund, to its Board of Directors.

Ahmad doroudianSergei stetsenkoHenri sant cassiaUniversity college londonPsychedelic medicine associationConscious fundBetterlife pharma incQlife pharmaUniversity collegeMagic medChief executiveஹென்றி சந்த் காசியாபல்கலைக்கழகம் கல்லூரி லண்டன்சைகடெலிக் மருந்து சங்கம்உணர்வு நிதிவாழ்க்கை பார்மா

BetterLife Pharma Inc welcomes The Conscious Fund founder Henri Sant-Cassia to its board of directors

BetterLife Pharma welcomes The Conscious Fund founder Henri Sant-Cassia to its board of directors Sant-Cassia is a founding partner of The Conscious Fund, a US$60 million fund that is one of the most active venture funds in the field of psychedelic medicine BetterLife also announced that Sergei Stetenko has resigned from its board of directors BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) announced it had appointed The Conscience Fund’s founder Henri Sant-Cassia to its board of directors. Sant-Cassia is a founding partner of The Conscious Fund, a US$60 million fund that is one of the most active venture funds in the field of psychedelic medicine.

Ahmad doroudianSergei stetenkoHenri sant cassiaConscience fundConscious fundBetterlife pharma incNsx betrஹென்றி சந்த் காசியாஉணர்வு நிதி

BetterLife Closes $6 325 Million Bought Deal Public Offering of Units, Including Full Exercise of the Over-Allotment Option

VANCOUVER, British Columbia, May 28, 2021 (GLOBE NEWSWIRE) BetterLife Pharma Inc. (“ BetterLife” or the “ Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ) is pleased to announce the closing of its bought-deal public offering pursuant to which the Company issued 15,812,500 units of the Company (the “ Units”) at a price of $0.40 per Unit for aggregate gross proceeds to the Company of $6,325,000 (the “ Offering”), including the full exercise of the over-allotment option. The Offering was led by Research Capital Corporation as the sole underwriter and sole bookrunner (the “ Underwriter”). Common Share”) and one Common Share purchase warrant of the Company (a Warrant ). Each Warrant entitles the holder thereof to purchase one Common Share at an exercise price of $0.50 at any time up to 36 months from the closing of the Offering.

United statesUnited kingdomBritish columbiaAhmad doroudianCompany the unitsResearch capital corporationBetterlife pharma incCompanya common shareQlife pharmaCommon shareEach warrantUnited states securities actChief executiveBetterlife pharma inc stock exchangePress releaseHe betrf ca08772p2026

Microdose Psychedelic Insights: April Psychedelic Capital Investigates Clinical Trials & Real World Evidence & Going Mainstream: Mass Adoption

Microdose Psychedelic Insights: April Psychedelic Capital Investigates Clinical Trials & Real World Evidence & Going Mainstream: Mass Adoption Clinical Trials & RWE and 1:30 PM: Intro 1:45 PM: BETTERLIFE PHARMA INC. (CSE: BETR) Featuring Patrick Kroupa, Ahmad Doroudian, Justin Kirkland 2:15 PM: Clinical Trials & RWE Featuring Henri Sant-Cassia, Malcolm Barratt-Johnson, Matthew W. Johnson 2:45 PM: NanoPsy 3:15 PM: Going Mainstream: Mass Adoption Featuring Richard Skaife, Ronan Levy, Kathryn Tucker, Dustin Robinson 3:45 PM PharmAla Biotech Featuring Nicholas Kadysh & Justin Ling While PharmAla Biotech has a great team behind it, we re a relatively new company. I m excited to bring our story to the PsyCap audience, and to talk with Justin Ling about what I see as the future of the industry. - Nicholas Kadysh, President, PharmAla Biotech

Ahmad doroudianRichard skaifeNicholas kadysh justinNicholas kadyshMattheww johnsonJustin kirklandMalcolm barratt johnsonPatrick kroupaBojan krasic maxApril psycapDustin robinsonKathryn tuckerHenri sant cassia richard skaifeKristina spionjakKostenloser wertpapierhandelHenri sant cassia